{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:03:59Z","timestamp":1793833439554,"version":"4.6.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110256","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:05:45Z","timestamp":1784588745000},"page":"110256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Design and discovery of 1,4-dihydropyrimidinone-based noncovalent DprE1 inhibitors with integrated biological and computational validation against Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"181","author":[{"given":"Fady H.","family":"Fayek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai H.A.","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona F.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan H.","family":"Georgey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagwa M.","family":"Abdel Gawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110256_bb0005","series-title":"Global Tuberculosis Report 2025","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.bioorg.2026.110256_bb0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40249-023-01107-x","article-title":"Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Salari","year":"2023","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.bioorg.2026.110256_bb0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1017\/S0031182016002377","article-title":"Mycobacterial cell-wall biosynthesis: a multifaceted antibiotic target","volume":"145","author":"Abrahams","year":"2016","journal-title":"Parasitology"},{"key":"10.1016\/j.bioorg.2026.110256_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.603382","article-title":"Cell surface biosynthesis and remodeling pathways in mycobacteria reveal new drug targets","volume":"10","author":"Shaku","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110256_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000645","article-title":"High-content screening identifies DprE1 as a target for intracellular antimycobacterial inhibitors","volume":"5","author":"Christophe","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bioorg.2026.110256_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016869","article-title":"Decaprenylphosphoryl-\u03b2-D-ribose 2\u2032-epimerase, the target of benzothiazinones and dinitrobenzamides, is an essential enzyme in mycobacterium smegmatis","volume":"6","author":"Crellin","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.bioorg.2026.110256_bb0035","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1021\/acschembio.5b00237","article-title":"DprE1 is a vulnerable tuberculosis drug target due to its cell wall localization","volume":"10","author":"Brecik","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110256_bb0040","doi-asserted-by":"crossref","first-page":"8563","DOI":"10.1021\/acs.jmedchem.8b00281","article-title":"Overview of the development of DprE1 inhibitors for combating the menace of tuberculosis","volume":"61","author":"Chikhale","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110256_bb0045","doi-asserted-by":"crossref","first-page":"40659","DOI":"10.1021\/acsomega.2c05307","article-title":"Recent advances of DprE1 inhibitors against mycobacterium tuberculosis: computational analysis of physicochemical and ADMET properties","volume":"7","author":"Amado","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110256_bb0050","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.1171583","article-title":"Benzothiazinones kill mycobacterium tuberculosis by blocking arabinan synthesis","volume":"324","author":"Makarov","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2026.110256_bb0055","doi-asserted-by":"crossref","first-page":"13663","DOI":"10.1021\/ja106357w","article-title":"Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-\u03b2-D-ribose 2\u2032-epimerase DprE1 of mycobacterium tuberculosis","volume":"132","author":"Trefzer","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110256_bb0060","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/emmm.201303575","article-title":"Towards a new combination therapy for tuberculosis with next generation benzothiazinones","volume":"6","author":"Makarov","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bioorg.2026.110256_bb0065","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jiph.2022.08.016","article-title":"An insight into the discovery, clinical studies, compositions, and patents of macozinone: a drug targeting the DprE1 enzyme of mycobacterium tuberculosis","volume":"15","author":"Imran","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.bioorg.2026.110256_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109511","article-title":"2-Aminothiophene and 2-aminothiazole scaffolds as potent antimicrobial agents: design, synthesis, biological evaluation, and computational insights","volume":"170","author":"Chandrakanth","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110256_bb0075","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1021\/cb5007163","article-title":"2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1","volume":"10","author":"Neres","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110256_bb0080","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1021\/acs.jmedchem.9b01561","article-title":"Mycobacterium tuberculosis decaprenylphosphoryl-\u03b2-D-ribose oxidase inhibitors: expeditious reconstruction of suboptimal hits into a series with potent in vivo activity","volume":"63","author":"Borthwick","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110256_bb0085","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02020-19","article-title":"OPC-167832, a novel carbostyril derivative with potent antituberculosis activity as a DprE1 inhibitor","volume":"64","author":"Hariguchi","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.110256_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202506271","article-title":"Discovery of chemically distinct DprE1 inhibitors with sub-nanomolar predicted potency via virtual screening and molecular dynamics","volume":"11","author":"Fayek","year":"2026","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.110256_bb0095","doi-asserted-by":"crossref","first-page":"11354","DOI":"10.1073\/pnas.1205735109","article-title":"Structural basis of inhibition of mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors","volume":"109","author":"Batt","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2026.110256_bb0100","first-page":"559","article-title":"Cytotoxic and antimicrobial analysis of biosynthesized selenium nanoparticles from Solanum tuberosum peels","volume":"9","author":"Aktepe","year":"2025","journal-title":"Int. J. Agric. Environ. Food Sci."},{"key":"10.1016\/j.bioorg.2026.110256_bb0105","first-page":"351","article-title":"Investigation of the anticancer and antimicrobial effects of plant-derived synthesized selenium nanoparticles","volume":"11","author":"Yusifova","year":"2026","journal-title":"Adv. Biol. Earth Sci."},{"key":"10.1016\/j.bioorg.2026.110256_bb0110","first-page":"717","article-title":"Phenolic analysis and antimicrobial potential of Glycyrrhiza glabra L. plant root extract","volume":"10","author":"Aktepe","year":"2025","journal-title":"MAS J. Appl. Sci."},{"key":"10.1016\/j.bioorg.2026.110256_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157265","article-title":"Nordihydroguaiaretic acid (NDGA) exhibits potent anti-biofilm and antimicrobial activity against methicillin-resistant Staphylococcus aureus and Candida albicans","author":"Fan","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bioorg.2026.110256_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300099","article-title":"DprE1 inhibitors: enduring aspirations for future antituberculosis drug discovery","volume":"18","author":"Yadav","year":"2023","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.110256_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114145","article-title":"Identification of thiophene-benzenesulfonamide derivatives for the treatment of multidrug-resistant tuberculosis","volume":"231","author":"Qin","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110256_bb0130","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.1021\/acs.jmedchem.8b01356","article-title":"Identification and profiling of hydantoins \u2014 a novel class of potent antimycobacterial DprE1 inhibitors","volume":"61","author":"Rogacki","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110256_bb0135","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1021\/acs.jmedchem.0c00107","article-title":"Optimization of hydantoins as potent antimycobacterial decaprenylphosphoryl-\u03b2-D-ribose oxidase (DprE1) inhibitors","volume":"63","author":"Balabon","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110256_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107062","article-title":"DprE1 inhibitors: an insight into the recent developments and synthetic approaches","volume":"209","author":"Shahin","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2026.110256_bb0145","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2024.2403744","article-title":"Novel hybrids of 1,2,3-triazole-benzoxazole as DprE1 inhibitors","volume":"39","author":"Singh","year":"2024","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110256_bb0150","doi-asserted-by":"crossref","first-page":"29586","DOI":"10.1038\/s41598-025-14734-1","article-title":"Pyrazolopyridine\u2013pyrimidone hybrids as potential DprE1 inhibitors: design, synthesis, and biological evaluation as antitubercular agents","volume":"15","author":"Shah","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110256_bb0155","doi-asserted-by":"crossref","first-page":"11315","DOI":"10.1038\/s41598-024-61901-x","article-title":"Identification of DprE1 inhibitors for tuberculosis through integrated in silico approaches","volume":"14","author":"Dash","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110256_bb0160","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1021\/jm401382v","article-title":"Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts kill mycobacterium tuberculosis and are efficacious in vivo","volume":"56","author":"Shirude","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110256_bb0165","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bioorg.2018.12.018","article-title":"Identification of a pyrimidinetrione derivative as a potent DprE1 inhibitor by structure-based virtual ligand screening","volume":"85","author":"Gao","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110256_bb0170","first-page":"91","article-title":"Computational approaches in tuberculosis drug discovery","volume":"22","author":"Ekins","year":"2023","journal-title":"In Silico Models Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110256_bb0175","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nm.3262","article-title":"Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis","volume":"19","author":"Pethe","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2026.110256_bb0180","doi-asserted-by":"crossref","DOI":"10.2174\/0118715265361578250504110100","article-title":"Flavonoids: potential novel inhibitors of mycobacterium tuberculosis","volume":"25","author":"Kisimba","year":"2025","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/j.bioorg.2026.110256_bb0185","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/antibiotics3030317","article-title":"Drug resistance mechanisms in mycobacterium tuberculosis","volume":"3","author":"Palomino","year":"2014","journal-title":"Antibiotics"},{"key":"10.1016\/j.bioorg.2026.110256_bb0190","series-title":"Comprehensive Heterocyclic Chemistry II","author":"Katritzky","year":"1996"},{"key":"10.1016\/j.bioorg.2026.110256_bb0195","series-title":"The Chemistry of Heterocycles: Structure, Reactions, Syntheses, and Applications","author":"Eicher","year":"2013"},{"key":"10.1016\/j.bioorg.2026.110256_bb0200","first-page":"360","article-title":"Synthesis of dihydropyrimidinones","volume":"23","author":"Biginelli","year":"1893","journal-title":"Gazz. Chim. Ital."},{"key":"10.1016\/j.bioorg.2026.110256_bb0205","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2174\/1385272824999200616111228","article-title":"Recent advances in Biginelli-type reactions","volume":"24","author":"Heravi","year":"2020","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.bioorg.2026.110256_bb0210","doi-asserted-by":"crossref","first-page":"S510","DOI":"10.1016\/j.arabjc.2011.06.010","article-title":"Solvent-free synthesis of 3,4-dihydropyrimidin-2(1H)-ones\/thiones via Biginelli reaction reaction promoted by bismuth(III)nitrate or PPh3 without solvent","volume":"9","author":"Slimi","year":"2016","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2026.110256_bb0215","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2250575","article-title":"Discovery of pyrimidine-tethered benzothiazole derivatives as novel anti-tubercular agents towards multi- and extensively drug-resistant mycobacterium tuberculosis","volume":"38","author":"Hemeda","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110256_bb0220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/00397911.2019.1692225","article-title":"Synthesis of N-aryl 2-chloroacetamides and their chemical reactivity towards various types of nucleophiles","volume":"50","author":"Abdel-Latif","year":"2020","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2026.110256_bb0225","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1128\/AAC.00699-11","article-title":"Clofazimine analogs with efficacy against experimental tuberculosis and reduced potential for accumulation","volume":"55","author":"Lu","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.110256_bb0230","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/JCM.36.2.362-366.1998","article-title":"Rapid, low-technology MIC determination with clinical mycobacterium tuberculosis isolates by using the microplate Alamar blue assay","volume":"36","author":"Franzblau","year":"1998","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110256_bb0235","first-page":"E2510","article-title":"Identification of a small molecule with activity against drug-resistant and persistent tuberculosis","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2026.110256_bb0240","doi-asserted-by":"crossref","first-page":"i-viii","DOI":"10.1046\/j.1469-0691.2003.00789.x","article-title":"Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts","volume":"9","author":"Rodriguez-Tudela","year":"2003","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bioorg.2026.110256_bb0245","unstructured":"CLSI, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, CLSI M38, third ed., Clinical and Laboratory Standards Institute, Wayne, PA, 2017."},{"key":"10.1016\/j.bioorg.2026.110256_bb0250","unstructured":"CLSI, Performance Standards for Antimicrobial Susceptibility Testing, CLSI M100, 28th ed., Clinical and Laboratory Standards Institute, Wayne, PA, 2018."},{"key":"10.1016\/j.bioorg.2026.110256_bb0255","unstructured":"CLSI, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, CLSI M07, 11th ed., Clinical and Laboratory Standards Institute, Wayne, PA, 2018."},{"key":"10.1016\/j.bioorg.2026.110256_bb0260","unstructured":"CLSI, Performance Standards for Antimicrobial Disk Susceptibility Tests, CLSI M02, 13th ed., Clinical and Laboratory Standards Institute, Wayne, PA, 2018."},{"key":"10.1016\/j.bioorg.2026.110256_bb0265","unstructured":"CLSI, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, CLSI M27, fourth ed., Clinical and Laboratory Standards Institute, Wayne, PA, 2017."},{"key":"10.1016\/j.bioorg.2026.110256_bb0270","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jpha.2015.11.005","article-title":"Methods for in vitro evaluation of antimicrobial activity","volume":"6","author":"Balouiri","year":"2016","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.bioorg.2026.110256_bb0275","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.apsb.2025.01.023","article-title":"Revolutionizing tuberculosis treatment: breakthroughs, challenges, and hope on the horizon","volume":"15","author":"Kufa","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2026.110256_bb0280","first-page":"615","article-title":"Whole cell target engagement identifies novel inhibitors of mycobacterium tuberculosis decaprenylphosphoryl-\u03b2-D-ribose oxidase, ACS","volume":"1","author":"Batt","year":"2015","journal-title":"Infect. Dis."},{"key":"10.1016\/j.bioorg.2026.110256_bb0285","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110256_bb0290","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.110256_bb0295","doi-asserted-by":"crossref","first-page":"13473","DOI":"10.1038\/s41598-018-31316-6","article-title":"Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with mycobacterium tuberculosis DprE1","volume":"8","author":"Richter","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110256_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.139746","article-title":"Design, synthesis, and in silico ADME prediction of some novel bis(1,3,4-thiadiazoles) encapsulated lipid\u2013chitosan nanocapsules decorated with magnetic nanoparticles and their potential anti-helicobacter pylori activity","volume":"296","author":"Salem","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2026.110256_bb0305","series-title":"Discovery Studio Visualizer, Version 24.1.0 [Software]","author":"Dassault Syst\u00e8mes BIOVIA","year":"2024"},{"key":"10.1016\/j.bioorg.2026.110256_bb0310","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.3390\/molecules27072105","article-title":"Molecular dynamics simulations: advances and applications","volume":"27","author":"Filipe","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110256_bb0315","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1741-7007-9-71","article-title":"Molecular dynamics simulations and drug discovery","volume":"9","author":"Durrant","year":"2011","journal-title":"BMC Biol."},{"key":"10.1016\/j.bioorg.2026.110256_bb0320","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.bioorg.2026.110256_bb0325","doi-asserted-by":"crossref","first-page":"18","DOI":"10.53964\/jmbdd.2024002","article-title":"Virtual screening, molecular dynamics, MM-PBSA, and in silico studies in search of potent novel fibroblast growth factor receptor 4 inhibitors","volume":"3","author":"Fayek","year":"2024","journal-title":"J. Mod. Biol. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110256_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108295","article-title":"Triazole-linked thiazolidinedione\u2013benzothiazole hybrids: design and biological evaluation as AChE inhibitors","volume":"157","author":"Almatary","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110256_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.661230","article-title":"Molecular docking and dynamics simulation revealed the potential inhibitory activity of ACEIs against SARS-CoV-2 targeting the hACE2 receptor","volume":"9","author":"Al-Karmalawy","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2026.110256_bb0340","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1021\/acs.jpcb.4c04901","article-title":"Introductory tutorials for protein dynamics simulations using GROMACS","volume":"128","author":"Lemkul","year":"2024","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bioorg.2026.110256_bb0345","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1021\/ja0356131","article-title":"An approach to developing a force field for molecular simulation of martensitic phase transitions between phases with subtle differences in energy and structure","volume":"126","author":"Tuble","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110256_bb0350","article-title":"Molecular dynamics simulation in concrete research: a systematic review of techniques, models and future directions","volume":"76","author":"Barbhuiya","year":"2023","journal-title":"J. Build. Eng."},{"key":"10.1016\/j.bioorg.2026.110256_bb0355","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/minf.201100135","article-title":"Free energy calculations by the MM-PBSA method","volume":"31","author":"Homeyer","year":"2012","journal-title":"Mol. Inform."},{"key":"10.1016\/j.bioorg.2026.110256_bb0360","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bioorg.2026.110256_bb0365","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A","article-title":"Approximate atomic surfaces from LCPO","volume":"20","author":"Weiser","year":"1999","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.110256_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191838","article-title":"CLC-pred: in silico prediction of human cell line cytotoxicity","volume":"13","author":"Lagunin","year":"2018","journal-title":"PloS One"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:13:33Z","timestamp":1791407613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826007923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":74,"alternative-id":["S0045206826007923"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110256","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and discovery of 1,4-dihydropyrimidinone-based noncovalent DprE1 inhibitors with integrated biological and computational validation against Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110256"}}